TY - JOUR T1 - Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing鈥檚 disease: 12-month, Phase III pasireotide study JO - Endocrine UR - http://eprints.whiterose.ac.uk/101612/ PY - 2016/11/01 AU - Findling JW AU - Fleseriu M AU - Newell-Price J AU - Petersenn S AU - Pivonello R AU - Kandra A AU - Pedroncelli AM AU - Biller BMK ED - DO - DOI: 10.1007/s12020-016-0978-6 VL - 54 IS - 2 SP - 516 EP - 523 Y2 - 2025/06/26 ER -